1. Home
  2. INHD vs QTTB Comparison

INHD vs QTTB Comparison

Compare INHD & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INHD
  • QTTB
  • Stock Information
  • Founded
  • INHD 2019
  • QTTB 2015
  • Country
  • INHD United States
  • QTTB United States
  • Employees
  • INHD N/A
  • QTTB N/A
  • Industry
  • INHD
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • INHD
  • QTTB Health Care
  • Exchange
  • INHD Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • INHD 19.8M
  • QTTB 19.0M
  • IPO Year
  • INHD 2023
  • QTTB N/A
  • Fundamental
  • Price
  • INHD $1.32
  • QTTB $1.90
  • Analyst Decision
  • INHD
  • QTTB Hold
  • Analyst Count
  • INHD 0
  • QTTB 8
  • Target Price
  • INHD N/A
  • QTTB $24.00
  • AVG Volume (30 Days)
  • INHD 2.8M
  • QTTB 108.9K
  • Earning Date
  • INHD 05-02-2025
  • QTTB 05-08-2025
  • Dividend Yield
  • INHD N/A
  • QTTB N/A
  • EPS Growth
  • INHD N/A
  • QTTB N/A
  • EPS
  • INHD N/A
  • QTTB N/A
  • Revenue
  • INHD $1,559,595.00
  • QTTB N/A
  • Revenue This Year
  • INHD N/A
  • QTTB N/A
  • Revenue Next Year
  • INHD N/A
  • QTTB N/A
  • P/E Ratio
  • INHD N/A
  • QTTB N/A
  • Revenue Growth
  • INHD 287.83
  • QTTB N/A
  • 52 Week Low
  • INHD $1.11
  • QTTB $1.38
  • 52 Week High
  • INHD $19.78
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • INHD 32.33
  • QTTB 55.70
  • Support Level
  • INHD $1.22
  • QTTB $1.56
  • Resistance Level
  • INHD $1.54
  • QTTB $2.02
  • Average True Range (ATR)
  • INHD 0.16
  • QTTB 0.15
  • MACD
  • INHD 0.11
  • QTTB 0.03
  • Stochastic Oscillator
  • INHD 36.21
  • QTTB 74.73

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: